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BSTRACT
 
Background
 
The emergence of resistance to anti-
microbial agents within the salmonellae is a world-
wide problem that has been associated with the use
of antibiotics in livestock. Resistance to ceftriaxone
and the fluoroquinolones, which are used to treat in-
vasive salmonella infections, is rare in the United
States. We analyzed the molecular characteristics of
a ceftriaxone-resistant strain of 
 
Salmonella enterica
 
serotype typhimurium isolated from a 12-year-old boy
with fever, abdominal pain, and diarrhea.
 
Methods
 
We used pulsed-field gel electrophoresis
and analysis of plasmids and 
 
b
 
-lactamases to com-
pare the ceftriaxone-resistant 
 
S. enterica
 
 serotype ty-
phimurium from the child with four isolates of this
strain obtained from cattle during a local outbreak of
salmonellosis.
 
Results
 
The ceftriaxone-resistant isolate from the
child was indistinguishable from one of the isolates
from cattle, which was also resistant to ceftriaxone.
Both ceftriaxone-resistant isolates were resistant to
13 antimicrobial agents; all but one of the resistance
determinants were on a conjugative plasmid of 160
kb that encoded the functional group 1 
 
b
 
-lactamase
CMY-2. Both ceftriaxone-resistant isolates were close-
ly related to the three other salmonella isolates ob-
tained from cattle, all of which were susceptible to
ceftriaxone.
 
Conclusions
 
This study provides additional evi-
dence that antibiotic-resistant strains of salmonella
in the United States evolve primarily in livestock. Re-
sistance to ceftriaxone, the drug of choice for inva-
sive salmonella disease, is a public health concern,
especially with respect to children, since fluoroquin-
olones, which can also be used to treat this disease,
are not approved for use in children. (N Engl J Med
2000;342:1242-9.)
 
©2000, Massachusetts Medical Society.
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F the estimated 1.4 million salmonella in-
fections that occur each year in the United
States, most are in children and the eld-
erly and approximately 600 are fatal.
 
1
 
 Sep-
ticemia complicates at least 7 percent of the 40,000
culture-confirmed infections that are reported each
year.
 
1,2
 
 Although antibiotics are not essential for the
treatment of most cases of salmonellosis, they can be
lifesaving in persons with invasive disease. Expanded-
spectrum cephalosporins (e.g., ceftriaxone) are com-
monly used to treat salmonella infections in children
because of their pharmacodynamic properties and
O
 
the very low prevalence of resistance to these agents.
Since 1991, salmonella species that are resistant to
expanded-spectrum cephalosporins have been report-
ed in several countries, including Argentina, Turkey,
Algeria, Saudi Arabia, Greece, Tunisia, and France.
 
3-12
 
In these isolates, a variety of 
 
b
 
-lactamases from func-
tional groups 1 and 2 have been described.
 
13
 
 How-
ever, only three ceftriaxone-resistant infections have
been reported in the United States, and each was as-
sociated with international travel.
 
14
 
 These 3 isolates
were detected in 1995 in a national survey of more
than 4000 isolates.
 
14
 
 Ceftriaxone-resistant salmonel-
la have been reported very rarely by national surveil-
lance systems in the United Kingdom and Denmark,
further demonstrating the low prevalence of ceftri-
axone-resistant salmonella worldwide
 
15
 
 (and Threl-
fall EJ: personal communication).
Epidemiologic investigations have demonstrated
that in the United States, the use of antimicrobial
agents in livestock is the principal cause of the emer-
gence and dissemination of resistance to antimicro-
bial agents in strains of nontyphoidal salmonella.
 
16-18
 
However, few investigations have been successful in
tracing antibiotic-resistant infections in humans to a
source on a farm. We used molecular methods to es-
tablish a connection between a domestically acquired
ceftriaxone-resistant salmonella infection in a child
and related isolates from cattle.
 
CASE REPORT
 
In April 1998, a 12-year-old boy living in western Nebraska
had acute abdominal pain with fever. The boy had been well with
the exception of a sinus infection treated with amoxicillin–clavu-
lanate. He had finished his 10-day course of treatment 4 days be-
fore the onset of abdominal pain. He began a prophylactic regimen
of ampicillin–sulbactam and underwent an appendectomy. His-
tologic examination of the appendix showed acute mucosal in-
flammation but no involvement of the serosa or muscularis. Two
days after surgery, treatment with ampicillin–sulbactam was dis-
continued and treatment with amoxicillin–clavulanate was begun.
The following day the patient began to have diarrhea, and a stool
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culture yielded 
 
Salmonella enterica
 
 serotype typhimurium. The
patient was discharged and had an uneventful recovery.
The isolate was analyzed at the Nebraska Public Health Labo-
ratory and found to be resistant to ampicillin, chloramphenicol,
tetracycline, sulfisoxazole, kanamycin, and streptomycin as well as
to broad-spectrum cephalosporins (e.g., cephalothin) and expand-
ed-spectrum cephalosporins (e.g., ceftriaxone, which is used in
humans, and ceftiofur, which is used in animals), aztreonam, cefox-
itin, gentamicin, and tobramycin. Further investigation was con-
ducted by epidemiologists at the Nebraska Department of Health
and Human Services and the Centers for Disease Control and
Prevention (CDC). In March 1998, the patient’s father had treat-
ed calves with a severe diarrheal disorder from his own herd and
three other herds. Several of the calves had died. Stool specimens
from ill cattle in each herd were analyzed at the University of
Nebraska Panhandle Research and Extension Center and yielded
 
S. enterica
 
 serotype typhimurium. During the two-week period
before his illness, the boy had not accompanied his father on visits
to other herds and had not traveled outside the United States.
Reports of the boy’s illness prompted an investigation by public
health officials. No additional ceftriaxone-resistant salmonella in-
fections were reported in Nebraska or adjoining states.
 
METHODS
 
Bacterial Strains and Antibiotic Susceptibility
 
Five isolates of 
 
S. enterica
 
 serotype typhimurium were studied:
the one from the boy and four from cattle (one from each herd
associated with the outbreak of salmonellosis). The susceptibility
of these isolates to antimicrobial agents was determined by the
broth-microdilution or disk-diffusion method in accordance with
the standards of the National Committee for Clinical Laboratory
Standards
 
19,20
 
 and with the E test, according to the manufactur-
er’s recommendations (AB Biodisk, Solona, Sweden). The double
disk-diffusion assay was used to screen for the presence of extend-
ed-spectrum 
 
b
 
-lactamases according to published methods.
 
21
 
 Iso-
lates were serotyped and phage typed at the CDC with the use
of standard methods.
 
22
 
Pulsed-Field Gel Electrophoresis and Plasmid Analysis
 
Genomic DNA suitable for pulsed-field gel electrophoresis
(PFGE) was prepared according to published methods and digest-
ed with the restriction endonuclease 
 
Xba
 
I (Roche, Indianapolis).
 
23
 
Three salmonella isolates, including a strain of 
 
S. enterica
 
 serotype
typhimurium known as definitive phage type 104 (DT104), from
ill persons in Nebraska were used for comparison. Plasmids en-
coded by 
 
Escherichia coli
 
 V517,
 
24
 
 R1,
 
25
 
 and PDK9 (CDC strain
collection) were used as size standards. Plasmid DNA from all
strains studied was isolated with the use of either a kit (Qiagen
midi-preps, Qiagen, Valencia, Calif.) or a modified alkaline lysis
procedure.
 
26
 
Transconjugation Studies
 
The isolate from the child, one of the cattle isolates (cattle iso-
late 1), and the DT104 isolate (which is resistant to ampicillin and
susceptible to nalidixic acid) were transconjugated with 
 
E. coli
 
C600N,
 
27
 
 which is resistant to nalidixic acid and susceptible to
ampicillin, with the use of standard methods.
 
28
 
 DT104 was trans-
conjugated with C600N to serve as a negative control.
 
29
 
Isoelectric Focusing
 
Isoelectric focusing was performed according to the method of
Mathew et al.
 
30
 
 at 10°C (Multiphor apparatus, Pharmacia LKB,
Uppsala, Sweden) with prepared polyacrylamide-gel plates (pH
range, 3.5 to 9.5) (Pharmacia). TEM-1, TEM-2, K1, SHV-1, and
P99 
 
b
 
-lactamases were used as standards.
 
Amplification, Sequencing, and Hybridization
 
The polymerase-chain-reaction (PCR) primers that were used to
identify the 
 
ampC
 
 gene of 
 
Citrobacter freundii
 
 and TEM-related
sequences have been described previously.
 
28,31
 
 The sequence of
both strands was analyzed. Southern hybridization was performed
according to standard methods
 
32
 
 with DNA probes labeled with
digoxigenin-11-deoxyuridine triphosphate (Roche).
 
RESULTS
 
Susceptibility to Antibiotics, Serotype, and Phage Type 
of the Isolates
 
The isolate from the child and the four isolates
from cattle were serotyped at the CDC and found to
be 
 
S. enterica
 
 serotype typhimurium variant Copen-
hagen. All five isolates had the same pattern of phage
lysis, which did not match previously described type
designations. Susceptibility testing revealed that the
isolate from the child and cattle isolate 1 had an iden-
tical pattern, including resistance to ceftriaxone (min-
imal inhibitory concentration, »64 µg of ceftriax-
one per milliliter) and ceftiofur (minimal inhibitory
concentration, »16 µg of ceftiofur per milliliter). Al-
though not resistant to ceftriaxone or ceftiofur, the
other three isolates from cattle were resistant to five
antimicrobial agents (ampicillin, tetracycline, kanamy-
cin, streptomycin, and sulfisoxazole). Double disk-
diffusion testing showed that the 
 
b
 
-lactamase that
conferred resistance to ceftriaxone and other expand-
ed-spectrum cephalosporins was not inhibited by the
 
b
 
-lactamase inhibitor clavulanate and was therefore
not phenotypically classified as an extended-spectrum
 
b
 
-lactamase (functional group 2be).
 
13
 
PFGE
 
PFGE was used to determine the molecular relat-
edness of the isolate from the child and the four cattle
isolates (Fig. 1). All five isolates had similar restric-
tion-fragment patterns; however, they had a number
of bands that differed from those of 
 
S. enterica
 
 ser-
otype typhimurium DT104 and two non-DT104
control strains of 
 
S. enterica
 
 serotype typhimurium
(REF42 and REF65) that were isolated in Nebraska.
The isolate from the child and cattle isolate 1, the
two ceftriaxone-resistant isolates, were closely related
except for differences in bands K and P (Fig. 1). Both
ceftriaxone-resistant isolates also contained a 160-kb
band (band I) as well as a slightly larger band (band
H) that the ceftriaxone-susceptible isolates from cat-
tle did not have. Cattle isolates 2 and 4 were identi-
cal, whereas cattle isolate 3, although very similar to
cattle isolates 2 and 4, differed with respect to band
K. Cattle isolate 1 was very similar to cattle isolates
2 and 4, except with respect to bands I and H. The
isolate from the child appeared to have the same
band K as cattle isolate 3. The origin of these differ-
ences was subsequently determined.
 
Transconjugation Experiments and Analysis of Plasmids
 
To determine whether ceftriaxone and other anti-
biotic-resistance factors of the isolate from the child
and cattle isolate 1 were mediated by plasmids, both
strains were transconjugated with 
 
E. coli
 
 C600N. The
 1244
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transconjugants exhibited decreased susceptibility to
all antimicrobial agents (including ceftriaxone, cef-
tiofur, and cefoxitin) to which the isolate from the
child and cattle isolate 1 were resistant, except kan-
amycin (data not shown). The results of PFGE used
to confirm the 
 
E. coli
 
 C600N lineage showed an ad-
ditional 
 
Xba
 
I band in each ceftriaxone-resistant trans-
conjugant. This new band was the same size as band
I in both ceftriaxone-resistant salmonella isolates, sug-
gesting that this band carried the genetic material
mediating resistance to ceftriaxone.
The isolates from the child and the cattle were an-
alyzed for plasmids. The two ceftriaxone-resistant iso-
lates (lanes 1 and 2 in Fig. 2A) both had plasmid
bands of 160 kb. The isolate from the child contained
two additional plasmids, one of 55 kb and one of
125 kb. The band of 125 kb was also present in cattle
isolates 2 and 3 (lanes 3 and 4, respectively, in Fig. 2A)
and cattle isolate 4 (data not shown). Plasmid bands
of 140 kb were seen in cattle isolates 1 and 2 (Fig. 2A).
The plasmid profiles of cattle isolates 2 and 4 were
indistinguishable (data not shown).
 
Figure 1.
 
 Results of Pulsed-Field Gel Electrophoresis of Isolates of 
 
Salmonella enterica 
 
Serotype Typhi-
murium from a 12-Year-Old Boy and Cattle.
Lanes 1 and 2 show control strains of 
 
S. enterica 
 
serotype typhimurium (REF42 and REF65, respective-
ly), lanes 3 and 4 
 
S. enterica 
 
serotype typhimurium definitive phage type 104 (DT104), lane 5 the isolate
from the child, lane 6 cattle isolate 2, lane 7 cattle isolate 3, lane 8 cattle isolate 4, and lane 9 cattle
isolate 1. The isolate from the child includes a unique band, labeled P. Bands H and I were found in
both the isolate from the child and cattle isolate 1. There were additional differences among the iso-
lates with respect to band K. Bands I, K, and P were all found to be of plasmid origin.
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The plasmid profiles of the salmonella isolates and
the 
 
E. coli
 
 C600N transconjugants resulting from
transconjugation with the isolate from the child and
cattle isolate 1 were compared. The ceftriaxone-resist-
ant transconjugants both contained the band of 160
kb that was found in cattle isolate 1 and the isolate
from the child (Fig. 2B), but not the bands of 55 kb
and 125 kb that were found in the isolate from the
child or the 140-kb band that was found in cattle
isolate 1.
b
 
-Lactamase Analysis
 
Isoelectric focusing was performed to characterize
the 
 
b
 
-lactamases present in the five salmonella iso-
lates and the ceftriaxone-resistant transconjugants.
Cattle isolates 2, 3, and 4 all expressed one 
 
b
 
-lacta-
mase with an isoelectric point of 5.4. This finding,
in conjunction with their antibiotic-resistance profile,
suggested that these isolates produced a TEM-1–
like 
 
b
 
-lactamase. The isolate from the child and cattle
isolate 1 produced not only the TEM-1–like 
 
b
 
-lac-
tamase but also one with an isoelectric point of at
least 9.0, suggestive of an AmpC-like enzyme. More-
over, all four ceftriaxone-resistant transconjugants con-
tained the AmpC-like 
 
b
 
-lactamase (isoelectric point,
»9.0), further suggesting that this 
 
b
 
-lactamase was
responsible for the ceftriaxone resistance and that it
was encoded on the conjugative plasmid of approx-
imately 160 kb. The TEM-1–like 
 
b
 
-lactamase was not
present in the transconjugants.
Specific primers for the 
 
ampC
 
 gene of 
 
C. freundii
 
were used to characterize the AmpC-like 
 
b
 
-lacta-
mase found in the isolate from the child, cattle iso-
late 1, and their transconjugants. This analysis yield-
ed a PCR product of the expected size (631 bp)
from the isolate from the child, cattle isolate 1, and
their transconjugants. Cattle isolates 2, 3, and 4 were
negative on PCR testing for the 631-bp amplicon.
These findings indicated that a 
 
b
 
-lactamase (isoelec-
tric point, »9.0) closely related to the 
 
ampC
 
 gene
of 
 
C. freundii
 
 was responsible for the ceftriaxone re-
sistance of these isolates.
To characterize the 
 
b
 
-lactamase with an isoelectric
point of 5.4 that was present in all the salmonella
isolates, primers specific for the TEM family of 
 
b
 
-lac-
tamases were used. All isolates were positive, but the
transconjugants were negative. This finding demon-
strated that the TEM-1–like 
 
b
 
-lactamase was not en-
coded on the same plasmid as the AmpC-like 
 
b
 
-lac-
tamase.
 
Figure 2.
 
 Plasmid Analysis of Isolates of 
 
Salmonella enterica
 
 Serotype Typhimurium and of Transconjugants.
The results for cattle isolate 4 are not shown. Panel A shows the 160-kb plasmid that was found in the isolate from the
child (lane 1) and cattle isolate 1 (lane 2); the 140-kb plasmid that was found in cattle isolates 1, 2 (lane 3), and 4; the
125-kb plasmid that was found in the isolate from the child and cattle isolates 2, 3 (lane 4), and 4; and the 55-kb plasmid
that was found only in the isolate from the child. Panel B shows the plasmids found in ceftriaxone-resistant transcon-
jugants of 
 
Escherichia coli C600N and S. enterica serotype typhimurium. The 160-kb conjugative plasmid found only in
the ceftriaxone-resistant cattle isolate 1 (lane 1) and the isolate from the child (lane 2) was transferred by transconjuga-
tion of these isolates with E. coli C600N (lanes 3 and 4, respectively). The 55-kb plasmid in the isolate from the child
was not transferred.
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To prove that the AmpC-like b-lactamase was en-
coded on the 160-kb plasmid that was found only in
the isolate of the child, cattle isolate 1, and their
transconjugants, C. freundii ampC-like PCR prod-
ucts were labeled and used as probes. Southern blot
analysis of a PFGE gel (Fig. 3) demonstrated that the
AmpC-like b-lactamase probe hybridized to band I,
which was found only in the ceftriaxone-resistant iso-
late from the child, cattle isolate 1, and their trans-
conjugants. Since transconjugation studies had shown
that the AmpC-like b-lactamase was derived from a
plasmid, we concluded that the additional band I was
the unique 160-kb plasmid that was found in the
ceftriaxone-resistant isolates.
Southern blot analysis demonstrated that the
TEM-1 b-lactamase was encoded on the plasmids in
all clinical isolates and not on the chromosome (data
not shown). This analysis demonstrated that TEM-1
was encoded on the 125-kb plasmid in the isolate
from the child and cattle isolate 3 and on the 140-kb
plasmid in cattle isolates 1, 2, and 4, raising the pos-
sibility that band K was derived from a plasmid. To
answer this question, we hybridized DNA, which had
been separated by PFGE, with a TEM-1 probe (Fig.
4). These results demonstrated that band K was de-
rived from a plasmid and represented the 125-kb
plasmid found in both the isolate from the child and
cattle isolate 3 and the 140-kb plasmid found in cat-
tle isolates 1, 2, and 4.
To determine whether the 55-kb plasmid that was
found in the isolate from the child represented band
P identified on PFGE analysis, plasmid DNA and
chromosomal DNA digested with XbaI were electro-
phoresed on the same gel. The analysis showed that
band P was the same size as the plasmid.
DNA Sequencing
The AmpC-like b-lactamase from the ceftriaxone-
resistant transconjugant of E. coli C600N and the
isolate from the child was completely sequenced and
found to be 100 percent homologous to the plas-
midic cephamycinase CMY-2.33
DISCUSSION
On the basis of reports sent to the CDC, we be-
lieve that this case represents the first documented
domestically acquired ceftriaxone-resistant salmonel-
la infection in the United States. Although the means
of transmission is not known, the child apparently
acquired the illness from cattle. Several lines of evi-
dence, in addition to the epidemiologic findings, sup-
port the hypothesis that the child’s gastrointestinal
infection was acquired from cattle on his family’s
ranch or nearby ranches that had had outbreaks of
salmonellosis among cattle. First, the isolate from the
child and all the cattle isolates were S. enterica sero-
type typhimurium variant Copenhagen and had the
same distinct pattern of phage lysis. Second, the iso-
Figure 3. Results of Pulsed-Field Gel Electrophoresis of Isolates
of Salmonella enterica Serotype Typhimurium from a 12-Year-
Old Boy and Cattle and of Transconjugants.
In each panel, lane 1 shows cattle isolate 2, lane 2 the isolate
from the child, and lanes 3 and 4 ceftriaxone-resistant transcon-
jugant of Escherichia coli C600N with the isolate from the child
and cattle isolate 1, respectively. In Panel A, band I was found
only in the ceftriaxone-resistant isolates and their ceftriaxone-
resistant transconjugants. In Panel B, Southern blot analysis
with cmy-2 PCR product as the probe indicates that band I is of
plasmid origin and corresponds to the 160-kb plasmid shown
in Figure 2. There is no hybridization in ceftriaxone-susceptible
cattle isolate 2.
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late from the child and one of the cattle isolates (cattle
isolate 1) had the same, extremely rare pattern of re-
sistance to antibiotics. Finally, the presence of plasmid
DNA could account for almost all the differences in
bands among the isolates that were found on PFGE.
These differences between cattle isolate 1 and the iso-
late from the child were in two bands (K and P) sub-
sequently shown to be of plasmid origin. Therefore,
the isolate from the child and cattle isolate 1 can be
considered to be the same strain. One additional band
(I), unique to the ceftriaxone-resistant isolates, was
also shown to be of plasmid origin and encoded a
CMY-2 b-lactamase as well as other antibiotic-resist-
ance genes. The only genomic differences among the
isolate from the child, cattle isolate 1, and the ceftri-
axone-susceptible cattle isolates lay in the larger size
of band H in both cattle isolate 1 and the isolate
from the child. According to the criteria of Tenover
et al. for analysis of banding patterns on PFGE, all
the isolates were highly related.34
Although antimicrobial therapy is not essential for
the treatment of most salmonella infections, such
therapy may be lifesaving in persons with invasive
disease. Expanded-spectrum cephalosporins, especial-
ly ceftriaxone, are frequently used empirically to treat
salmonella infections in children. The identification
of a domestically acquired CMY-2–mediated ceftri-
axone-resistant salmonella infection and its apparent
circulation in cattle suggest that such infections could
become more common in the United States, espe-
cially since the resistance to ceftriaxone is mediated
by a plasmid. There are few alternative antimicrobial
agents for the empirical treatment of salmonella in-
fections in children, since fluoroquinolones have not
been approved for use in children.
Our findings add to the accumulating body of
evidence suggesting that the use of antimicrobial
agents in livestock is the dominant source of resist-
ance to these agents in salmonella. Previous studies
have shown that salmonella isolates from both humans
and animals share antibiotic-resistance plasmids.35 Al-
though no information was available regarding the use
of antimicrobial agents among the four infected herds
on the patient’s ranch and neighboring ranches, the
results of PFGE suggest that the ceftriaxone-resistant
strain of S. enterica serotype typhimurium variant
Copenhagen that infected the child was present in at
least one herd. In addition, the ceftriaxone-resistant
isolate from cattle (cattle isolate 1) was closely related
to other, possibly endemic, ceftriaxone-susceptible
isolates of S. enterica serotype typhimurium variant
Copenhagen that were obtained during the same out-
break of salmonellosis (cattle isolates 2, 3, and 4).
It is probable that the use of antimicrobial agents
in cattle led to the selection of the ceftriaxone-resist-
ant strain that was subsequently transmitted to the
child. Although we were unable to establish its use
in these herds, an expanded-spectrum cephalosporin
(ceftiofur) is approved for use and is widely used in
domestic animals, including cattle. Other factors be-
sides cephalosporin use (e.g., the use of other anti-
biotics or unknown environmental factors) could have
selected for and maintained this plasmid within the
bacterial population in the involved herds. Although
Figure 4. Results of Pulsed-Field Gel Electrophoresis of Isolates
of Salmonella enterica Serotype Typhimurium from a 12-Year-
Old Boy and Cattle and of Transconjugants.
In each panel, lane 1 shows cattle isolate 2, lane 2 cattle isolate
1, lane 3 isolate from the child, lane 4 the ceftriaxone-resistant
transconjugant of Escherichia coli C600N and the isolate from
the child, and lane 5 the ceftriaxone-resistant transconjugant of
E. coli C600N and cattle isolate 1. Panel A shows band K, and
Panel B shows the results of Southern blot hybridization with a
952-bp TEM-1 PCR product amplified from the isolate from the
child. The results indicate that band K is of plasmid origin and en-
codes TEM-1 b-lactamase. The additional bands in lanes 1 and
2 of Panel B may indicate nicked or supercoiled forms of the
plasmids that encode TEM-1. There was no hybridization of the
TEM-1 probe in the ceftriaxone-resistant transconjugants (lanes
4 and 5).
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the means of transmission of the ceftriaxone-resist-
ant salmonella from the cattle to the child is not
known, it is unlikely that the child acquired the in-
fection through food. Therefore, even if salmonella
is eliminated from food, the circulation of highly re-
sistant strains in livestock constitutes a potential pub-
lic health threat, especially to farmers, ranchers, and
animal handlers.
The inoculum of salmonella necessary to cause ill-
ness in this child may have been lowered by the prior
treatment with amoxicillin–clavulanate and ampicil-
lin–sulbactam. The use of antibiotics during or be-
fore exposure has frequently been shown to predis-
pose persons to salmonella infections.16,36 Our findings
illustrate the need to use antimicrobial agents pru-
dently both in domestic animals and in humans. The
implementation of appropriate safeguards, including
restricting the use of certain antimicrobial agents in
livestock, may slow the evolution of antimicrobial
resistance in salmonella and prevent the transmission
of resistant strains of salmonella from livestock to
humans.
Our findings demonstrate the ability of nationwide
monitoring programs to detect new antibiotic-resist-
ant strains of bacteria before they become widely dis-
seminated. Continued surveillance for antibiotic-resist-
ant salmonella in livestock and humans is necessary,
particularly to monitor the incidence of ceftriaxone-
resistant strains. In this respect, testing for CMY-2–
mediated resistance will be useful to identify the spread
of related strains or plasmids in the United States.
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